Theres been very little human data to show a benefit from unapproved peptides, says Daniel M
While injections work well, many people prefer taking pills
To view or add a comment, sign in More Relevant Posts Corporate Financiers Notes: Insight of the Day - Global sales of GLP-1s (new class of weight-loss drugs) are expected to exceed USD 26 billion in 2025, 2x the figure in 2024
It translates milligrams into syringe units at the three concentrations discussed above
Medicare coverage for GLP-1 medications is currently very limited unless you have a diagnosis thats not related to weight loss, says Dave Knapp, founder of On the Pen , a community education website about GLP-1s
This is concluded from evidence provided by glucose consumption, 2-NBDG uptake and lactate production measurements as well as ECAR and OCR profiles (Figs 1 and 2)